• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内预测释放法在药物咀嚼胶中的应用。

In vivo predictive release methods for medicated chewing gums.

机构信息

Institute of Pharmacy and Biochemistry, Therapeutical Life Sciences, Johannes Gutenberg University, Mainz, Germany.

出版信息

Biopharm Drug Dispos. 2012 Oct;33(7):417-24. doi: 10.1002/bdd.1796. Epub 2012 Jul 11.

DOI:10.1002/bdd.1796
PMID:22674680
Abstract

Understanding the performance of a drug product in vivo plays a key role in the development of meaningful in vitro drug release methodology. In case of functional chewing gums, the mode and the mechanism of release and the site of application differ significantly from other conventional solid oral dosage forms and require a special consideration to extract meaningful information from clinical studies. In the current study, suitable drug release methodology was developed to predict the in vivo performance of an investigated chewing gum product. Different parameters of the drug release testing apparatus described in the Ph. Eur. and Pharmeuropa were evaluated. Drug release data indicate that the parameters, chewing distance, chewing frequency and twisting motion, affect the drug release. Higher drug release was observed when the frequency was changed from 40 chews/min to 60 chews/min for apparatus A and B, as was the case for the twisting motion when changed from 20º to 40º for apparatus B. As far as the chewing distance is concerned, the release rate was in the following order; apparatus A: 0.3 mm > 0.5 mm > 0.7 mm; apparatus B: 1.4 mm > 1.6 mm > 1.8 mm. A suitable apparatus set-up for in vitro release testing was identified. The method will be useful for the establishment of in vitro in vivo correlations (IVIVC) for medicated chewing gums. Interchangeability of the apparatus for a product is not generally recommended without prior knowledge of the performance of the product, as the construction and principle of operation for the apparatus differ considerably.

摘要

理解药物在体内的性能在有意义的体外药物释放方法的开发中起着关键作用。对于功能性咀嚼胶,释放的方式和机制以及应用部位与其他常规的固体口服剂型有很大的不同,需要特别考虑从临床研究中提取有意义的信息。在本研究中,开发了合适的药物释放方法来预测所研究的咀嚼胶产品的体内性能。评估了欧洲药典和 Pharmeuropa 中描述的药物释放测试仪器的不同参数。药物释放数据表明,参数(咀嚼距离、咀嚼频率和扭转运动)会影响药物释放。当仪器 A 和 B 的频率从 40 次/分钟增加到 60 次/分钟时,药物释放量更高,当仪器 B 的扭转运动从 20°增加到 40°时也是如此。就咀嚼距离而言,释放速率的顺序为:仪器 A:0.3mm>0.5mm>0.7mm;仪器 B:1.4mm>1.6mm>1.8mm。确定了适合体外释放测试的仪器设置。该方法将有助于建立含药咀嚼胶的体外体内相关性(IVIVC)。在没有产品性能预先知识的情况下,不建议一般互换仪器,因为仪器的结构和操作原理有很大的不同。

相似文献

1
In vivo predictive release methods for medicated chewing gums.体内预测释放法在药物咀嚼胶中的应用。
Biopharm Drug Dispos. 2012 Oct;33(7):417-24. doi: 10.1002/bdd.1796. Epub 2012 Jul 11.
2
Apparatus for studying in vitro drug release from medicated chewing gums.用于研究含药口香糖体外药物释放的装置。
Int J Pharm. 1999 Oct 28;189(1):57-65. doi: 10.1016/s0378-5173(99)00236-7.
3
Equipment for drug release testing of medicated chewing gums.药用口香糖药物释放测试设备。
J Pharm Biomed Anal. 2000 Apr;22(3):405-11. doi: 10.1016/s0731-7085(99)00307-6.
4
Use of dye as tracer of drug release from medicated chewing gums.使用染料作为药物口香糖药物释放的示踪剂。
Eur J Pharm Biopharm. 2008 Mar;68(3):811-7. doi: 10.1016/j.ejpb.2007.09.005. Epub 2007 Sep 21.
5
Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device.新型咀嚼装置3TabGum的制备及其释放特性评估
Eur J Pharm Sci. 2005 Apr;24(5):487-93. doi: 10.1016/j.ejps.2005.01.010.
6
Development and evaluation of a novel dissolution apparatus for medicated chewing gum products.一种新型药用口香糖产品溶出装置的研发与评价
Pharm Res. 1992 Feb;9(2):255-9. doi: 10.1023/a:1018901826635.
7
A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.一项随机、安慰剂对照研究,比较了两种茶苯海明制剂在晕动病和镇静方面的疗效。
Arzneimittelforschung. 2002;52(7):529-36. doi: 10.1055/s-0031-1299926.
8
A biorelevant in vitro release/permeation system for oral transmucosal dosage forms.用于口服黏膜给药剂型的生物相关体外释放/渗透系统。
Int J Pharm. 2012 Jul 1;430(1-2):104-13. doi: 10.1016/j.ijpharm.2012.03.050. Epub 2012 Apr 3.
9
Development of postcompressional textural tests to evaluate the mechanical properties of medicated chewing gum tablets with high drug loadings.开发压缩后纹理测试,以评估高载药量药用咀嚼片的机械性能。
J Texture Stud. 2018 Feb;49(1):30-37. doi: 10.1111/jtxs.12287. Epub 2017 Aug 15.
10
Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.缓释剂型的监管方面:使用流通系统进行溶出度测试的特殊情况。
Boll Chim Farm. 1993 Apr;132(4):105-15.

引用本文的文献

1
Formulation development, optimization, and evaluation of taste-masked medicated chewing gum of sertraline.舍曲林掩味药用口香糖的处方开发、优化及评价
Ther Deliv. 2025 Jul;16(7):621-636. doi: 10.1080/20415990.2025.2508685. Epub 2025 May 21.